Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,038,842 | 4,038,842 | 0 | $113.29M | $93.34M | 47.16% | -$19.95M |
| Kura Oncology, Inc.(KURA) | 1,849,947 | 1,849,947 | 0 | $26.60M | $39.46M | 19.94% | +$12.86M |
| Kinnate Biopharma Inc. | 9,671,643 | 9,671,643 | 0 | $22.92M | $25.73M | 13.00% | +$2.80M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 875,000 | 875,000 | 0 | $18.91M | $20.82M | 10.52% | +$1.92M |
| Lyell Immunopharma, Inc.(LYEL) | 8,325,000 | 8,325,000 | 0 | $16.15M | $18.56M | 9.38% | +$2.41M |